Kamada (KMDA) FCF Margin Growth (1y) (2013 - 2026)

Kamada (KMDA) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 74.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -1,043.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -573.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 734.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 301.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -45,890.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 407.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 610.00
10 Kamada 504.70 -73.15 Mn 19.12 Mn -66.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -66.00
Dec 31, 2025 398.00
Sep 30, 2025 -2,851.00
Jun 30, 2025 -2.00
Mar 31, 2025 -764.00
Dec 31, 2024 781.00
Sep 30, 2024 5,132.00
Jun 30, 2024 -757.00
Mar 31, 2024 981.00
Dec 31, 2023 919.00
Sep 30, 2023 699.00
Jun 30, 2023 -3,526.00
Mar 31, 2023 -2,128.00
Dec 31, 2022 -18.00
Sep 30, 2022 499.00
Jun 30, 2022 5,090.00
Mar 31, 2022 1,231.00
Dec 31, 2021 -4,478.00
Sep 30, 2021 -1,590.00
Jun 30, 2021 -4,328.00